Medicare Drug Price Negotiation Program Challenged in U.S. Court of Appeals
A challenge to the novel Medicare drug price negotiation program, created to lower prescription costs, has reached the U.S. Court of Appeals for the Fifth Circuit. Pharmaceutical manufacturers and related groups nationwide are contesting the program as unconstitutional. During the oral arguments in New Orleans, Judge Jennifer Walker Elrod noted the singular nature of the…